T. Rowe Price Associates’s Iovance Biotherapeutics IOVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.64M | Sell |
2,114,190
-289,890
| -12% | -$499K | ﹤0.01% | 1391 |
|
|
2025
Q1 | $8.01M | Sell |
2,404,080
-224,021
| -9% | -$746K | ﹤0.01% | 1152 |
|
|
2024
Q4 | $19.4M | Sell |
2,628,101
-474,811
| -15% | -$3.51M | ﹤0.01% | 997 |
|
|
2024
Q3 | $29.1M | Sell |
3,102,912
-379,490
| -11% | -$3.56M | ﹤0.01% | 902 |
|
|
2024
Q2 | $27.9M | Sell |
3,482,402
-1,785,462
| -34% | -$14.3M | ﹤0.01% | 869 |
|
|
2024
Q1 | $78.1M | Buy |
5,267,864
+1,991,262
| +61% | +$29.5M | 0.01% | 604 |
|
|
2023
Q4 | $26.6M | Sell |
3,276,602
-320,518
| -9% | -$2.61M | ﹤0.01% | 877 |
|
|
2023
Q3 | $16.4M | Sell |
3,597,120
-66,253
| -2% | -$301K | ﹤0.01% | 964 |
|
|
2023
Q2 | $25.8M | Sell |
3,663,373
-92,495
| -2% | -$651K | ﹤0.01% | 866 |
|
|
2023
Q1 | $22.9M | Sell |
3,755,868
-92,863
| -2% | -$567K | ﹤0.01% | 886 |
|
|
2022
Q4 | $24.6M | Sell |
3,848,731
-862,583
| -18% | -$5.51M | ﹤0.01% | 856 |
|
|
2022
Q3 | $45.1M | Buy |
4,711,314
+360,629
| +8% | +$3.45M | 0.01% | 679 |
|
|
2022
Q2 | $48M | Sell |
4,350,685
-805,961
| -16% | -$8.9M | 0.01% | 885 |
|
|
2022
Q1 | $85.9M | Buy |
5,156,646
+492,861
| +11% | +$8.21M | 0.01% | 784 |
|
|
2021
Q4 | $89M | Buy |
4,663,785
+39,057
| +0.8% | +$746K | 0.01% | 800 |
|
|
2021
Q3 | $114M | Sell |
4,624,728
-25,824
| -0.6% | -$637K | 0.01% | 724 |
|
|
2021
Q2 | $121M | Sell |
4,650,552
-484,904
| -9% | -$12.6M | 0.01% | 718 |
|
|
2021
Q1 | $163M | Sell |
5,135,456
-2,246,749
| -30% | -$71.1M | 0.02% | 612 |
|
|
2020
Q4 | $343M | Buy |
7,382,205
+452,991
| +7% | +$21M | 0.04% | 402 |
|
|
2020
Q3 | $228M | Sell |
6,929,214
-343,216
| -5% | -$11.3M | 0.03% | 453 |
|
|
2020
Q2 | $200M | Buy |
7,272,430
+491,999
| +7% | +$13.5M | 0.03% | 472 |
|
|
2020
Q1 | $203M | Buy |
6,780,431
+270,575
| +4% | +$8.1M | 0.03% | 406 |
|
|
2019
Q4 | $180M | Buy |
6,509,856
+4,773
| +0.1% | +$132K | 0.02% | 501 |
|
|
2019
Q3 | $118M | Buy |
6,505,083
+481,180
| +8% | +$8.76M | 0.02% | 579 |
|
|
2019
Q2 | $148M | Buy |
6,023,903
+2,531,169
| +72% | +$62.1M | 0.02% | 535 |
|
|
2019
Q1 | $33.2M | Buy |
3,492,734
+187,707
| +6% | +$1.79M | ﹤0.01% | 1018 |
|
|
2018
Q4 | $29.2M | Buy |
3,305,027
+182,528
| +6% | +$1.62M | 0.01% | 1013 |
|
|
2018
Q3 | $35.1M | Sell |
3,122,499
-169,788
| -5% | -$1.91M | 0.01% | 1039 |
|
|
2018
Q2 | $42.1M | Buy |
3,292,287
+1,546,143
| +89% | +$19.8M | 0.01% | 955 |
|
|
2018
Q1 | $29.5M | Buy |
+1,746,144
| New | +$29.5M | ﹤0.01% | 1048 |
|
|
2016
Q4 | – | Sell |
-480,700
| Closed | -$3.96M | – | 2558 |
|
|
2016
Q3 | $3.96M | Buy |
+480,700
| New | +$3.96M | ﹤0.01% | 1449 |
|